ArticleFrontiers in artificial intelligence2026
Deep ensemble optimized models for probabilistic CTV breast segmentation.
Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: To optimize radiotherapy treatment and minimize toxicities, effective segmentation of organs-at-risk (OARs) and clinical target volume (CTV) is essential. Deep learning (DL) models can achieve high segmentation accuracy through careful tuning. However, their reliability also hinges on addressing uncertainties stemming from variability in clinical contouring practices. This study systematically evaluates six advanced DL models for automatic CTV segmentation in whole-breast radiotherapy. It further leverages the top-performing models to construct a probability map, aiming to improve consistency and mitigate bias in clinical predictions. Methods: Planning CTs from a single institute (861: training, 100: "temporal" test) were used to train six models for right/left breast CTV segmentation simultaneously: UNet, SegResNetDS, DynUNet (MONAI), nnU-Net (Total Segmentator), MedSAM2 (MS-A: CT-specific weights, MS-B: general medical-image weights). MedSAM2 employed a strong caveat: it needs a spatial prompt to make the prediction. Standard metric such as Dice Similarity Coefficient, Average Surface Distance and Hausdorff Distance were used to evaluate prediction compared to ground truth. A Friedman test followed by Results: All models attained overall satisfactory performance [comparable to IOV (Dice = 0.90)]. Among them, UNet, DynUNet, nnU-Net, and MedSAM2-A demonstrated the highest equivalent accuracy, with average ASD = 1.5 mm and HD95 = 3.8 mm. Conover test displayed more subtle differences with lower performance of two models out of six (SegResNetDS, MS-B), which were therefore removed for the subsequent built of a probability map. The analysis of the 100 vs. 25% isoprobability volumes on the temporal test dataset (average difference = 123 ± 81 cm Discussion: Different DL architectures were optimized, trained and validated on a large cohort of patients, successfully predicting the CTV for both right/left breast. In addition, the first attempt to provide uncertainty maps was achieved through successful computation of DL model-based probability maps. Supported by CCM 2024 (Ministry of Health).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.